| View |
2023-07-07-0211
|
LIVE ATTENUATED ROTAVIRUS VACCINE
|
ROTARIX
|
BR-674
|
AROLD740AE
|
Packaging Lot: (Box and PFS): AROLD740AE
|
31-Oct-25
|
13 July 2023
|
| View |
2023-07-17-0231
|
LIVE ATTENUATED ROTAVIRUS VACCINE
|
ROTARIX
|
BR-674
|
AROLD748AA
|
Packaging Lot (Box and PFS): AROLD748AA
|
31-Oct-25
|
21 July 2023
|
| View |
2023-07-21-0242
|
TETANUS TOXOID (ADSORBED)
|
T-VAC
|
BR-326
|
2592I004D
|
Packaging Lot: (Box and Ampoule): 2592I004D
|
31-Oct-25
|
27 July 2023
|
| View |
LRV2023-09-27-0311
|
INACTIVATED PURIFIED RABIES VACCINE (VERO CELL)
|
INDIRAB
|
BR-658
|
62C22009A
|
Packaging Lot (Box and Vial): 62C22009A; (Diluent [ampoule]): 62F22001A
|
31-Oct-25
|
03 October 2023
|
| View |
LRV2023-10-02-0321
|
DIPHTHERIA, TETANUS AND PERTUSSIS (ACELLULAR COMPONENT), HEPATITIS B (rDNA), POLIOMYELITIS (INACTIVATED) AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE (ADSORBED)
|
INFANRIX HEXA
|
BR-508
|
A21CE329
|
Packaging Lot: (Box): A21CE329C; (Pre-filled Syringe): A21LE329C; (Vial): A21FE329C; (Needle 25G x 1"): 22006026
|
31-Oct-25
|
05 October 2023
|
| View |
LRV2024-01-18-0012
|
DIPHTHERIA, TETANUS AND PERTUSSIS (ACELLULAR COMPONENT), HEPATITIS B (rDNA), POLIOMYELITIS (INACTIVATED) AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE (ADSORBED)
|
INFANRIX HEXA
|
BR-508
|
A21CE334
|
Packaging Lot (Box): A21CE334B; (PFS): A21LE334B; (Vial): A21FE334B; (Needle 25G x 1"): 2207024
|
31-Oct-25
|
24 January 2024
|
| View |
LRV2024-01-18-0013
|
DIPHTHERIA, TETANUS AND PERTUSSIS (ACELLULAR COMPONENT), HEPATITIS B (rDNA), POLIOMYELITIS (INACTIVATED) AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE (ADSORBED)
|
INFANRIX HEXA
|
BR-508
|
A21CE333
|
Packaging Lot (Box): A21CE333C; (PFS): A21LE333C; (Vial): A21FE333C; (Needle 25G x 1"): 2207025
|
31-Oct-25
|
24 January 2024
|
| View |
LRV2024-01-24-0025
|
EQUINE ANTI-RABIES IMMUNOGLOBULIN
|
VINRAB
|
BRP-090
|
08AR23037
|
Packaging Lot (Box and Vial): 08AR23037
|
31-Oct-25
|
29 January 2024
|
| View |
LRV2024-01-24-0026
|
EQUINE ANTI-RABIES IMMUNOGLOBULIN
|
VINRAB
|
BRP-090
|
08AR23036
|
Packaging Lot (Box and Vial): 08AR23036
|
31-Oct-25
|
29 January 2024
|
| View |
LRV2024-01-24-0027
|
EQUINE ANTI-RABIES IMMUNOGLOBULIN
|
VINRAB
|
BRP-090
|
08AR23038
|
Packaging Lot (Box and Vial): 08AR23038
|
31-Oct-25
|
29 January 2024
|
| View |
LRV2024-02-02-0041
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06823027
|
Packaging Lot (Box and Vial): A06823027
|
31-Oct-25
|
08 February 2024
|
| View |
LRV2024-02-02-0042
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06823029
|
Packaging Lot (Box and Vial): A06823029
|
31-Oct-25
|
08 February 2024
|
| View |
LRV2024-02-02-0043
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06823028
|
Packaging Lot (Box and Vial): A06823028
|
31-Oct-25
|
08 February 2024
|
| View |
LRV2024-02-07-0047
|
EQUINE ANTI-RABIES IMMUNOGLOBULIN
|
VINRAB
|
BRP-090
|
08AR23040
|
Packaging Lot (Box and Vial): 08AR23040
|
31-Oct-25
|
13 February 2024
|
| View |
LRV2024-02-07-0048
|
EQUINE ANTI-RABIES IMMUNOGLOBULIN
|
VINRAB
|
BRP-090
|
08AR23039
|
Packaging Lot (Box and Vial): 08AR23039
|
31-Oct-25
|
13 February 2024
|
| View |
LRV2024-02-20-0058
|
EQUINE ANTI-RABIES IMMUNOGLOBULIN
|
VINRAB
|
BRP-090
|
08AR23041
|
Packaging Lot (Box and Vial): 08AR23041
|
31-Oct-25
|
21 February 2024
|
| View |
LRV2024-02-20-0059
|
EQUINE ANTI-RABIES IMMUNOGLOBULIN
|
VINRAB
|
BRP-090
|
08AR23042
|
Packaging Lot (Box and Vial): 08AR23042
|
31-Oct-25
|
22 February 2024
|
| View |
LRV2024-02-22-0061
|
MEASLES, MUMPS, RUBELLA (MMR) VACCINE (LIVE, ATTENUATED)
|
PRIORIX
|
BR-415
|
A69CF701A
|
Packaging Lot (Box): A69CF701A; (Vial): A69FF701A; (Diluent): A69DF701A; (Needle 25G x 5/8"): 2211025
|
31-Oct-25
|
28 February 2024
|
| View |
LRV2024-02-22-0062
|
HEPATITIS A VACCINE (INACTIVATED, ADSORBED)
|
AVAXIM 80
|
BR-513
|
W3J31
|
Packaging Lot (Box): W3J312V; (PFS): W3J31
|
31-Oct-25
|
28 February 2024
|
| View |
LRV2024-03-05-0076
|
EQUINE ANTI-RABIES IMMUNOGLOBULIN
|
VINRAB
|
BRP-090
|
08AR23043
|
Packaging Lot (Box and Vial): 08AR23043
|
31-Oct-25
|
08 March 2024
|